Business Investment Opportunities

1. New Age Tea Company: The company is revolutionising the tea industry with a focus on making tea healthier and more accessible to the general public. 2. Extensive Tea Sourcing Network: Gathers and procures the freshest tea leaves from over 250+ tea gardens, estates, factories, small tea growers, and small tea help groups in the entire region, ensuring quality and variety in the products. 3. Custom Blending and Packaging: With a blending capacity of 5,000 kg of tea per day, curate and blend tea to meet the specific needs of clients. The products are packaged in food-grade pouches, ensuring freshness and quality, before being distributed to consumers. 4. Diverse Product Portfolio: Boasts a portfolio of 50+ products with over 90 SKUs, offering a wide range of tea varieties to cater to different tastes and preferences. 5. Extensive Distribution Network: The tea is distributed to direct customers as well as 20,000+ retailers, ensuring widespread availability and accessibility across various channels. 6. Founders and Marquee Investors: Founded by two serial & visionary entrepreneurs, the company is backed by marquee investors such as ITI Growth Opportunities Fund and Vsure Investment Affairs, providing strategic guidance and support for growth and expansion. 7. Experienced Team: With a total team strength of 50+ experienced professionals, including experts in tea procurement, tea sales, finance, management, and operations, the company is well-equipped to navigate the complexities of the tea industry and drive business success. This number of employees are required to handle the expanding business operations. There has been a significant growth in revenue from last year to the current year because of the increase in clientele and order volume and launch of new variants as well. Overall, the company stands out as a dynamic and innovative tea company with a strong emphasis on quality, innovation, and customer satisfaction, poised for continued growth and success in the market.

The company specializes in manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents and rapid diagnostic tests. - The company serves over 100 clients, including hospitals, diagnostic laboratories, and POCT providers. - Our revenue model includes direct sales to healthcare institutions and laboratories. - We engage in B2B sales of uncut sheets of urine strips to other manufacturers. - Company forms OEM partnerships and offers custom packaging solutions for clients. - We also conduct sales through distributors and marketing partners. - Our promoters bring over three decades of expertise in the healthcare industry, specializing in the development and production of in vitro diagnostic products. - We have a strong background in quality assurance, adhering to ISO 13485:2016 and GMP standards. - The company is ISO 13485:2016 and GMP certified. - We hold a startup certificate and are selected under the BIRAC scheme for innovative product development. - The company collaborates with academic and research institutions, including a notable partnership with IIT Kanpur for developing a TB RT-PCR kit under the BIRAC scheme. - Our product range includes a comprehensive array of clinical diagnostic reagents and test kits. - We offer custom packaging options tailored to client requirements. - Company is committed to continuous improvement and total quality assurance. - Our highlights showcase our dedication to delivering superior-quality diagnostic products, fostering strong industry relationships, and maintaining a robust quality management system. - We boast a state-of-the-art manufacturing plant in Bhopal, fully compliant with Indian FDA, WHO, and ISO 13485 standards. - Our manufacturing capacity includes: - Rapid Card: 5 million tests/month. - Biochemistry: 10,000 liters of reagents/month. - Hematology: 25,000 liters of reagents/month. - Urine Strip: 300,000 strips/day. - The company has a highly motivated and experienced team excelling in manufacturing, quality control, regulatory compliance, and supply chain management. - We have a provision for a 3-row assembly room, ensuring efficient and reliable production to meet extensive testing capabilities. - Our facility is a testament to our commitment to high-quality manufacturing and our readiness to seize future business opportunities while maintaining the highest standards of compliance and efficiency.

The company specializes in manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents and rapid diagnostic tests. - The company serves over 100 clients, including hospitals, diagnostic laboratories, and POCT providers. - Our revenue model includes direct sales to healthcare institutions and laboratories. - We engage in B2B sales of uncut sheets of urine strips to other manufacturers. - Company forms OEM partnerships and offers custom packaging solutions for clients. - We also conduct sales through distributors and marketing partners. - Our promoters bring over three decades of expertise in the healthcare industry, specializing in the development and production of in vitro diagnostic products. - We have a strong background in quality assurance, adhering to ISO 13485:2016 and GMP standards. - The company is ISO 13485:2016 and GMP certified. - We hold a startup certificate and are selected under the BIRAC scheme for innovative product development. - The company collaborates with academic and research institutions, including a notable partnership with IIT Kanpur for developing a TB RT-PCR kit under the BIRAC scheme. - Our product range includes a comprehensive array of clinical diagnostic reagents and test kits. - We offer custom packaging options tailored to client requirements. - Company is committed to continuous improvement and total quality assurance. - Our highlights showcase our dedication to delivering superior-quality diagnostic products, fostering strong industry relationships, and maintaining a robust quality management system. - We boast a state-of-the-art manufacturing plant in Bhopal, fully compliant with Indian FDA, WHO, and ISO 13485 standards. - Our manufacturing capacity includes: - Rapid Card: 5 million tests/month. - Biochemistry: 10,000 liters of reagents/month. - Hematology: 25,000 liters of reagents/month. - Urine Strip: 300,000 strips/day. - The company has a highly motivated and experienced team excelling in manufacturing, quality control, regulatory compliance, and supply chain management. - We have a provision for a 3-row assembly room, ensuring efficient and reliable production to meet extensive testing capabilities. - Our facility is a testament to our commitment to high-quality manufacturing and our readiness to seize future business opportunities while maintaining the highest standards of compliance and efficiency.

1. A rapidly growing brand of stylish luggage solutions designed for the modern traveler. 2. Products and services range from expandable carry-ons to ergonomic backpacks, travel accessories, hardshell spinner suitcases, and adventure gear. 3. Serves over 380 customers nationwide, including retail customers, corporate clients, and leading e-commerce players, and we manufacture 60,000 bags monthly. 4. Led by a team of seasoned professionals with over 20 years of experience in the travel goods industry. 5. Strong ties with Amazon and Flipkart, recognized as one of the top luggage brands for customer satisfaction and brand loyalty. 6. With 50 employees roles in marketing team, sales team, and logistics.

Firm manufactures and sells tent & canopy structures. We have a large in-house manufacturing unit and display facility. Our clients are hotels, resorts and event management companies. Since inception, we have served 1,000+ clients across India. We procure the raw materials such as fabrics & steel structures from 15-20 large vendors. Our business is operating well and aims at achieving INR 200 crore turnover in 4 years' time. In order to achieve our this mission, we are looking to raise funds to increase our scale of operations. Have a well trained technical staff. Founder of the company has 17 years of industry experience. Business owned assets include machinery, tools & equipment, laptops and furniture. Our current facility is rented and is 30,000 sq. ft. Out of this total land size, we use about 18,000 sq ft as a manufacturing unit and rest 12,000 sq ft as a display area. After raising funds, we plan to buy & move into a larger facility to scale up our operation. Need more factory space to execute the expansion plan.

The company is specialized in sheet metal production, retail and luxury furniture production as well as machine building. - We have our own workshop of 400 square meters and a new building of 240 square meters which is under construction, equipped with CNC laser cutting machines (TRUMPF Laser 2600W and TRUMPF laser 4000W) for sheets and pipes, CNC press brake, plate rolling machine and wide range of welding machines (MIG/MAG, TIG). - We are trying very strong to export our products to the European Union and to enter new markets. Until now we have been working as subcontractors for well-known worldwide companies for retail furniture, office and luxury furniture, automotive industries. - ENECA (a local non-governmental organization based in Nis) which, through the Start for a Job fund, awarded our company a grant for the purchase of equipment. - We were involved in the European Union support program for the development of municipalities - EU PRO - The program is implemented by the United Nations Office for Project Services (UNOPS) in cooperation with the Ministry of European Integration (MEI) and relevant ministries and institutions of the Government of the Republic of Serbia. Successful cooperation in the procurement of new equipment and socially responsible business. - Innovation fund of Serbia - Agreement on non-reimbursed financing of the project in connection with the suppression of the effect of the Covid pandemic (production of disinfection tunnels) and agreement on the financing of the Bioethanol mist burner project. Successful cooperation on the realization of two innovation projects. - We are the owner of the patent Bioethanol fireplace with automatic combustion control. - Since its establishment in 2017, the company records constant growth of around 30%. - We want to expand our business by finding bigger and more reliable partners for metal processing services, which will enable our faster and more intense growth through manufacturing agreements, and subcontracting. - Our country and our local authority have a great deal for foreign investments. The city of Sabac is committed to creating a good business environment. They offer to potential investors a wide range of options for their business, with different benefits. - Have 40 clients but 70% of the orders come from 3 clients. - On average we produce 50 metal tables per month. This will increase when we shift to the new facility soon.

Business Highlights: - Founded 4 years ago, began with a COVID-19 experiment using 1,300 samples, achieving an impressive 99.77% accuracy compared to RT-PCR. - Intellectual property: Secured a patent grant, solidifying our innovative approach in AI-driven diagnostics. - Accelerator & industry recognition: Selected for The Roux Institute’s Future of Healthcare acceleration program, providing mentorship and strategic growth opportunities. - Non-dilutive & early investment traction: Gained momentum with multiple grants and secured a $50K pre-seed investment, fueling research and development. - E. coli study success: Conducted a preclinical study demonstrating 87% accuracy, further validating our RF-based pathogen detection technology. - Funding & resources: Currently leveraging USD 725K in total grants and credits, including K in USD 70 K grants received, USD 350K in Google Cloud credits, and an expected USD 305K SBIR grant from NSF. - Industry partnerships & market strategy: -- NorDx is set to be our first commercial client upon market entry. - Recognition & awards: -- Accepted into the Nvidia Inception Program for AI innovation. -- Runner-up in the AWS x Nvidia pitch competition in Austin, positioning business at the forefront of AI-powered diagnostics. - Market Launch & Revenue. - Fundraising progress: Raising USD 3M to commercialize, with USD 105K secured through SAFE notes and strong investor interest. - Business Model & Revenue Potential: Projected first-year revenue of USD 3M, with sales of 600 diagnostic units upon launch. Scalable B2B model targeting diagnostic labs, hospitals, and healthcare providers. - Potential for recurring revenue streams through AI-powered diagnostic subscriptions and consumables. - Regulatory & Clinical Traction for a Competitive Edge. Ongoing clinical validation and regulatory alignment with CLIA/CAP-accredited labs. RF-based diagnostics provide a faster, non-invasive alternative to traditional molecular testing. - With high asset valuation, driven by significant equipment costs, the company stands out in the diagnostics sector with its advanced technological infrastructure. - With a compact team of 6 skilled employees, the business emphasizes agility and innovation in its operations, facilitating quick progress in the fast-paced diagnostic technology sector.

Updates on the business: The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids. The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University. Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program. Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation. We have received an installation license for such end products and as the project progresses we will add new products to the list: - Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption; - Hemp oil in drops for oral consumption > 0.2% THC; - Hemp oil for sublingual oral consumption (spray) > 0.2% THC; - Soft cannabis capsules for oral consumption > 0.2% THC; - Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption. At the moment we have: License and permits; Architectural and engineering plans; Purchase offers from equipment suppliers; All described production processes and laboratories; Long-term land lease for 30+ years with first an option of first to purchase it; Long-term lease and right of build on the neighboring land for the second stage of construction; The entire legal structure of the holding; Verification of processes and architectural solutions under EU GACP & EU GMP standards. By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years. Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards. The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line. Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.

Located in Bharatpur, our industrial bakery specializes in crafting high-quality cookies and bread with an emphasis on long shelf life, directly catering to both retail and wholesale clients in the Nepalese market. - Employing a dedicated team of 52, we have positioned ourselves as a leading bakery products manufacturer with a robust distribution network in Chitwan, serving over 5,000 retail outlets. - Our innovative approach in the food and bakery sector has fortified our reputation as a trusted brand, particularly known for our craftsmanship in cookies and bread. - Last fiscal year, we achieved an impressive average daily sales figure indicating strong demand and customer loyalty in the market. - With a team of 35 skilled salesmen working across a 70 km radius, we maintain a strong local presence, efficiently managing our in-house sales and distribution operations. - We actively engage in partnerships with minimarkets, optimizing our direct sales revenue streams and ensuring our bakery products reach a broad spectrum of consumers across different sectors, including hotels and industries. - Our monthly sales experienced a decline due to a change in government policy. Previously, we supplied tiffins to schools under a government contract. However, the current administration did not renew or grant the contract, which has directly impacted our revenue.